Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Correlative studies (flow on peripheral blood day 100 post-ASCT) from BMT CTN 0702 find CD8+CD38+Eomes+ T-cells as indicative of functional high-risk myeloma (relapse w/ in 24 mos) post-autologous stem cell transplant.”
Title: CD8+CD38+ T cells identify functional high-risk multiple myeloma after autologous transplant: BMT CTN 0702 correlates
Authors: Nezar Mehanna, Andriy Derkach, Billel Gasmi, Theodora Anagnostou, Heather J. Landau, Oscar B. Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Sham Mailankody, Urvi A. Shah, Carlyn R. Tan, Saad Z. Usmani, Sergio A. Giralt, Alexander M. Lesokhin, David J. Chung
You can read the Full Article on Blood Neoplasia.
You can find other articles featuring Robert Orlowski on OncoDaily.
